The stock jumped by 6.3% today to hit a CMP of 308.00 rupees. Consider exploring this stock for a buy.
Here's why -
a) The stock is available at a fwdPE of 12.36, which is one of the lowest amongst all pharma stocks
b) Although sales are growing slowly, the PAT is zooming at over 20% growth
c) The PAT per quarter has been in upwards of 18 crs over last 3 quarters
d) There is preferential allotment of shares to a private equity firm which has recently jacked up the prices. (the stock grew by 37% in two months)
e) The current dividend yield is 1.14% only. But given the increase in profits this year, I expect an increase in dividend to 5 rupees a share. It wont be more than this as the company is looking at expansion opportunities and acquisitions .. where internal accruals may be more handy than debt.
That apart, I found another swanky news item on Investsmartindia. Diabetes, Cardiology and Anti-infectives are growing areas in the healthcare segment. Buy in low numbers now and increase stake if it drops anywhere.
Sunday, April 2, 2006
Unichem Labs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment